아시아태평양의 디지털 PCR 시장 : 용도별, 최종사용자별, 국가별 - 분석과 예측(2024-2034년)

Introduction to Asia-Pacific Digital PCR Market

The Asia-Pacific digital PCR (d-PCR) market is projected to reach $695.5 million by 2034 from $144.4 million in 2024, growing at a CAGR of 17.02% during the forecast period 2024-2034. The growing use of personalised medicine for genetic disorder screening and diagnosis has propelled the APAC digital PCR market's double-digit growth. Digital PCR (dPCR) is used in this patient-specific method to precisely identify and measure uncommon genetic mutations connected to a range of cancers. The need for quick and accurate diagnostic solutions is also being fuelled by the region's rising infectious disease prevalence. Droplet digital PCR, nanoplate technology, and microfluidic platforms are examples of technological advancements that are improving dPCR capabilities and greatly bolstering the market's growth in the Asia-Pacific area.

Market Introduction

The Asia-Pacific (APAC) region is seeing strong, double-digit growth in the digital polymerase chain reaction (dPCR) market, which is quickly becoming popular as a state-of-the-art diagnostic technique. The broad use of dPCR in clinical and research applications is being fuelled by increased government programs, increased investments in healthcare infrastructure, and improved research funding. The need for high-precision diagnostics that facilitate early disease detection and efficient treatment monitoring is increasing in APAC due to the rising incidence of infectious diseases, genetic disorders, and cancers.

Advanced dPCR technologies have greatly increased sensitivity, specificity, and throughput. Examples of these technologies include droplet digital PCR, nanoplate systems, and microfluidic platforms. These developments support targeted therapies and personalised medicine by enabling the accurate quantification of low-abundance biomarkers, such as uncommon genetic mutations. Additionally, quicker turnaround times and lower operating costs are being achieved through smooth integration into standard clinical workflows made possible by advancements in automation and intuitive software interfaces.

The APAC digital PCR market is well-positioned for further growth and technological advancement, which will ultimately change the molecular diagnostics landscape throughout the region. This is due to the fact that both established industry leaders and up-and-coming startups are investing in research and development to create solutions for the region's particular clinical challenges.

Market Segmentation:

Segmentation 1: by Application

• Clinical and Research Application
• Environmental Application
• Other Application

Segmentation 2: by End User

• Academic and Research Institutes
• Hospitals and Clinics
• Diagnostic Centers
• Pharmaceutical and Biopharmaceutical Companies
• Other End User

Segmentation 3: by Country

• China
• Japan
• South Korea
• Australia
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific digital PCR market has been extensively segmented based on various categories, such as application, end user, and country. This can help readers understand which segments account for the largest share and which are well-positioned to grow in the coming years.

Competitive Strategy: The Asia-Pacific digital PCR market has numerous established players with product portfolios. Key players in the APAC digital PCR market analyzed and profiled in the study involve established players offering products for digital PCR.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts, who have analyzed company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• RevoSketch Inc.
• JN Medsys
• Sysmex Corporation

Table of Contents

Executive Summary

Scope and Definition

1 Markets

• 1.1 Market Overview
  • 1.1.1 Workflow of Digital PCR
  • 1.1.2 Comparison of qPCR and dPCR
• 1.2 Trends: Current and Future Impact Assessment
  • 1.2.1 Integration with Next-Generation Sequencing (NGS)
  • 1.2.2 Increased Real-time Monitoring and Point-of-care Applications of Digital PCR
  • 1.2.3 Increasing Product Launches in d-PCR Ecosystem
• 1.3 Supply Chain Overview
• 1.4 Research and Development Review
  • 1.4.1 Patent Filing Trend (by Region)
  • 1.4.2 Patent Filing Trend (by Country)
  • 1.4.3 Patent Filing Trend (by Year)
• 1.5 Ongoing Digital PCR Clinical Trials
• 1.6 Regulatory Landscape
  • 1.6.1 Asia Pacific
    • 1.6.1.1 Japan
    • 1.6.1.2 China
• 1.7 Market Dynamics Overview
  • 1.7.1 Market Drivers
    • 1.7.1.1 Increasing Adoption of Personalized Medicine for Screening and Diagnostics of Genetic Disorders such as Rare Diseases and Cancer
    • 1.7.1.2 Increasing Incidence of Infectious Diseases
    • 1.7.1.3 Technological Advancement in dPCR to Enhance Market Growth
  • 1.7.2 Market Restraints
    • 1.7.2.1 High Cost of Platforms Associated with Digital-PCR
    • 1.7.2.2 Shortage of Skilled Professionals and Trained Laboratory Technicians
  • 1.7.3 Market Opportunities
    • 1.7.3.1 Increased Use of Digital-PCR-Based Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan
    • 1.7.3.2 Growing Adoption of dPCR in Emerging Markets

2 Regions

• 2.1 Regional Summary
• 2.2 Drivers and Restraints
• 2.3 Asia-Pacific
  • 2.3.1 Regional Overview
  • 2.3.2 Driving Factors for Market Growth
  • 2.3.3 Factors Challenging the Market
  • 2.3.4 Application
  • 2.3.5 By End User
  • 2.3.6 China
  • 2.3.7 Australia
  • 2.3.8 South Korea
  • 2.3.9 Japan
  • 2.3.10 Rest-of-Asia-Pacific

3 Markets - Competitive Benchmarking & Company Profiles

• 3.1 Competitive Landscape
• 3.2 Market Share Analysis
• 3.3 Company Profile
  • 3.3.1 Genetron Holdings Limited
    • 3.3.1.1 Overview
    • 3.3.1.2 Top Products/Product Portfolio
    • 3.3.1.3 Top Competitors
    • 3.3.1.4 Target Customers
    • 3.3.1.5 Key Personnel
    • 3.3.1.6 Analyst View
  • 3.3.2 RevoSketch Inc.
    • 3.3.2.1 Overview
    • 3.3.2.2 Top Products/Product Portfolio
    • 3.3.2.3 Top Competitors
    • 3.3.2.4 Target Customers
    • 3.3.2.5 Key Personnel
    • 3.3.2.6 Analyst View
  • 3.3.3 JN Medsys
    • 3.3.3.1 Overview
    • 3.3.3.2 Top Products/Product Portfolio
    • 3.3.3.3 Top Competitors
    • 3.3.3.4 Target Customers
    • 3.3.3.5 Key Personnel
    • 3.3.3.6 Analyst View
  • 3.3.4 Sysmex Corporation.
    • 3.3.4.1 Overview
    • 3.3.4.2 Top Products/Product Portfolio
    • 3.3.4.3 Top Competitors
    • 3.3.4.4 Target Customers
    • 3.3.4.5 Key Personnel
    • 3.3.4.6 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast